Literature DB >> 11442250

The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer.

S F Sener1, S Milos, J L Feldman, C H Martz, D J Winchester, M Dieterich, G Y Locker, J D Khandekar, B Brockstein, M Haid, A Michel.   

Abstract

BACKGROUND: With the general acceptance of lumpectomy, axillary staging, and radiotherapy as local treatment for infiltrating breast cancer, an appreciation is evolving for the spectrum of vascular lesions that occur in the mammary skin after this treatment. Most of these lesions develop within the prior radiation field after breast conservation treatment. STUDY
DESIGN: A retrospective chart and slide review was conducted, consisting of five patients with cutaneous vascular lesions after breast conservation treatment for infiltrating breast cancer.
RESULTS: The latent time interval from definitive treatment of breast cancer to the clinical recognition of vascular lesions ranged from 5 to 11 years. Two patients did not have either arm or breast edema, two patients had breast edema, and the fifth patient had arm edema. Lesions arising in the irradiated mammary skin included extensive lymphangiectasia (one), atypical vascular lesions (two), and cutaneous angiosarcoma (four).
CONCLUSIONS: Atypical vascular lesions at the skin margins of mastectomy may be predictive of recurrence after resection of angiosarcoma. Excision of skin from the entire radiation field may be necessary to secure local control of the chest wall in patients with cutaneous angiosarcoma after therapeutic breast radiotherapy.

Entities:  

Mesh:

Year:  2001        PMID: 11442250     DOI: 10.1016/s1072-7515(01)00863-8

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

Review 1.  [Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].

Authors:  Carolin Nestle-Krämling; Edwin Bölke; Wilfried Budach; Matthias Peiper; Dieter Niederacher; Wolfgang Janni; Claus Ferdinand Eisenberger; Wolfram Trudo Knoefel; Axel Scherer; Stephan Ernst Baldus; Guido Lammering; Peter Arne Gerber; Christiane Matuschek
Journal:  Strahlenther Onkol       Date:  2011-08-16       Impact factor: 3.621

2.  Radiation-induced sarcoma of the breast: a systematic review.

Authors:  Grishma R Sheth; Lee D Cranmer; Benjamin D Smith; Lauren Grasso-Lebeau; Julie E Lang
Journal:  Oncologist       Date:  2012-02-14

3.  Author's Reply.

Authors:  Angoori Gnaneshwar Rao
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

4.  Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma.

Authors:  Wen Shen Looi; Julie A Bradley; Xiaoying Liang; Christiana M Shaw; Mark Leyngold; Raymond B Mailhot Vega; Eric D Brooks; Michael S Rutenberg; Lisa R Spiguel; Fantine Giap; Nancy P Mendenhall
Journal:  Int J Part Ther       Date:  2022-01-18

5.  Radiation-induced leiomyosarcoma: does antimetabolite chemotherapy contribute? A report of three cases.

Authors:  Bruce Brockstein; Arno Mundt; Daniel J Haraf; Mark Ferguson; Anthony Montag
Journal:  Sarcoma       Date:  2003

6.  Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature.

Authors:  Icro Meattini; Raffaella Santi; Daniele Scartoni; Irene Giacomelli; Carla De Luca Cardillo; Vieri Scotti; Donato Casella; Roberta Simoncini; Lorenzo Orzalesi; Jacopo Nori; Milena Paglierani; Lorenzo Livi
Journal:  Case Rep Oncol Med       Date:  2014-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.